Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-18

Clinical Trial Update: Rapid Structural and Functional Improvements in Following 0.19 mg Fluocinolone Acetonide (FAc) Implant in Diabetic Macular Edema Patients With Poor Visual Acuity: 12-month Audit Results From United Arab Emirates

View source ↗

Summary

A 12-month UAE audit reports rapid structural and functional improvements in diabetic macular edema patients with poor visual acuity treated with the 0.19 mg fl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ILUVIEN (fluocinolone acetonide)

Snippet

Sponsor: Benha University | Conditions: Diabetic Macular Edema | Status: UNKNOWN